salvinorin a has been researched along with 2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide in 1 studies
| Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide) | Trials (2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide) | Recent Studies (post-2010) (2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide) |
|---|---|---|---|---|---|
| 247 | 7 | 128 | 8 | 0 | 3 |
| Protein | Taxonomy | salvinorin a (IC50) | 2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide (IC50) |
|---|---|---|---|
| SUMO-1 | Homo sapiens (human) | 10.3 | |
| Mcl-1 | Homo sapiens (human) | 1.9188 | |
| neutrophil cytosol factor 1 | Homo sapiens (human) | 3.59 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.38 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.38 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.38 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.38 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
1 other study(ies) available for salvinorin a and 2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide
| Article | Year |
|---|---|
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |